EGFR and non-small cell lung carcinoma: According to the experts participating in the study, the annual incidence of NSCLC patients diagnosed with EGFR exon 20 insertion is estimated to be approximately 1–2 cases in Bosnia and Herzegovina, Bulgaria, and Estonia.